Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2000 TO 2099]"
topic_facet:"Clinical Trial, Phase II"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22&lookfor=%22Gupta%2C+Neeraj%22&type=Person
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22&lookfor=%22Gupta%2C+Neeraj%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2099%5D%22&filter%5B%5D=topic_facet%3A%22Clinical+Trial%2C+Phase+II%22&lookfor=%22Gupta%2C+Neeraj%22&type=Person
PubPharm (16)
1
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer
enthalten in:
Expert review of anticancer therapy
| 2023
von
Yang, J.
|
Zhou, C.
|
Jänne, P.
| +18
Wird geladen...
2
Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions : Exposure-Response Analyses of a Pivotal Phase I/II Study
enthalten in:
Clinical pharmacology and therapeutics
| 2022
von
Gupta, N.
|
Largajolli, A.
|
Witjes, H.
| +5
Wird geladen...
3
Population pharmacokinetics of mobocertinib in healthy volunteers and patients with non-small cell lung cancer
enthalten in:
CPT: pharmacometrics & systems pharmacology
| 2022
von
Gupta, N.
|
Pierrillas, P.
|
Hanley, M.
| +2
Wird geladen...
4
Population Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Kinase Inhibitor, in Patients With Advanced Solid Tumors
enthalten in:
Journal of clinical pharmacology
| 2022
von
Zhou, X.
|
Ouerdani, A.
|
Diderichsen, P.
| +1
Wird geladen...
5
Brigatinib Dose Rationale in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer : Exposure-Response Analyses of Pivotal ALTA Study
enthalten in:
CPT: pharmacometrics & systems pharmacology
| 2020
von
Gupta, N.
|
Wang, X.
|
Offman, E.
| +6
ErratumIn: CPT Pharmacometrics Syst Pharmacol. 2021 Sep;10(9):1119-1122. - PMID 34414680
Wird geladen...
6
Early-Onset Pulmonary Events Associated With Brigatinib Use in Advanced NSCLC
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2020
von
Ng, T.
|
Narasimhan, N.
|
Gupta, N.
| +3
CommentIn: J Thorac Oncol. 2020 Jul;15(7):1100-1102. - PMID 32593441
Wird geladen...
7
Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma
enthalten in:
British journal of haematology
| 2019
von
Kumar, S.
|
Grzasko, N.
|
Delimpasi, S.
| +9
Wird geladen...
8
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
enthalten in:
European journal of cancer (Oxford, England : 1990)
| 2019
von
Dimopoulos, M.
|
Grosicki, S.
|
Jędrzejczak, W.
| +10
Wird geladen...
9
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
enthalten in:
Haematologica
| 2018
von
San-Miguel, J.
|
Echeveste Gutierrez, M.
|
Špicka, I.
| +13
Wird geladen...
10
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma
enthalten in:
British journal of haematology
| 2018
von
Richardson, P.
|
Hofmeister, C.
|
Rosenbaum, C.
| +15
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2000-2099
Filter aufheben
Thema: Clinical Trial, Phase II
Medienart
16
Aufsätze
16
E-Artikel
16
E-Ressourcen
Zeitschriftentitel
2
British journal of haematology
2
CPT: pharmacometrics & systems pharmacology
2
European journal of cancer (Oxford, England : 1...
2
Journal of clinical pharmacology
2
Journal of thoracic oncology : official publica...
1
Blood
1
Clinical pharmacology and therapeutics
1
Expert review of anticancer therapy
1
Haematologica
1
Targeted oncology
1
The Lancet. Oncology
Alle anzeigen ...
weniger ...
Thema
Clinical Trial, Phase II
16
Journal Article
15
Research Support, Non-U.S. Gov't
10
Clinical Trial, Phase I
7
71050168A2
7
Boron Compounds
7
Glycine
7
Multicenter Study
7
TE7660XO1C
7
ixazomib
5
EC 2.7.10.1
5
Protein Kinase Inhibitors
4
7S5I7G3JQL
4
Antineoplastic Agents
4
Dexamethasone
4
Randomized Controlled Trial
3
Clinical Trial, Phase III
3
Proteasome Inhibitors
3
Pyrimidines
2
8N3DW7272P
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2000-
6
2020-
10
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
16
Englisch
Haven't found what you're looking for?
Wird geladen...